药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Biperiden
Pirarubicin
The risk or severity of adverse effects can be increased when Estramustine is combined with Pirarubicin.
Biperiden
Ravulizumab
The risk or severity of adverse effects can be increased when Estramustine is combined with Ravulizumab.
Biperiden
Ixekizumab
The risk or severity of adverse effects can be increased when Estramustine is combined with Ixekizumab.
Biperiden
Melengestrol
The risk or severity of adverse effects can be increased when Estramustine is combined with Melengestrol.
Biperiden
Dexamethasone isonicotinate
The risk or severity of adverse effects can be increased when Estramustine is combined with Dexamethasone isonicotinate.
Biperiden
Tepoxalin
The risk or severity of adverse effects can be increased when Estramustine is combined with Tepoxalin.
Biperiden
Meprednisone
The risk or severity of adverse effects can be increased when Estramustine is combined with Meprednisone.
Biperiden
Fluprednisolone
The risk or severity of adverse effects can be increased when Estramustine is combined with Fluprednisolone.
Biperiden
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Estramustine is combined with Antilymphocyte immunoglobulin (horse).
Biperiden
Peginterferon beta-1a
The risk or severity of adverse effects can be increased when Estramustine is combined with Peginterferon beta-1a.
Biperiden
Tixocortol
The risk or severity of adverse effects can be increased when Estramustine is combined with Tixocortol.
Biperiden
Vilanterol
The risk or severity of adverse effects can be increased when Estramustine is combined with Vilanterol.
Biperiden
Dinutuximab
The risk or severity of adverse effects can be increased when Estramustine is combined with Dinutuximab.
Biperiden
Olaparib
The risk or severity of adverse effects can be increased when Estramustine is combined with Olaparib.
Biperiden
Palbociclib
The risk or severity of adverse effects can be increased when Estramustine is combined with Palbociclib.
Biperiden
Idelalisib
The risk or severity of adverse effects can be increased when Estramustine is combined with Idelalisib.
Biperiden
Blinatumomab
The risk or severity of adverse effects can be increased when Estramustine is combined with Blinatumomab.
Biperiden
Vedolizumab
The risk or severity of adverse effects can be increased when Estramustine is combined with Vedolizumab.
Biperiden
Fluprednidene
The risk or severity of adverse effects can be increased when Estramustine is combined with Fluprednidene.
Biperiden
Obinutuzumab
The risk or severity of adverse effects can be increased when Estramustine is combined with Obinutuzumab.